FDA Warning Letter — Imperial Palace Commodity (Dongguan) Co., Ltd.

Case 692842 — FEI 3014838570

The FDA took a Warning Letter action against Imperial Palace Commodity (Dongguan) Co., Ltd. on Jan 27, 2025 (Dong Guan, China). The action was issued by CDER and concerns drugs products.

Action Details

Facility
Imperial Palace Commodity (Dongguan) Co., Ltd.
Date
Jan 27, 2025
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Dong Guan (China)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.